6.180PLN+0.49%Mkt Cap: 38.51M $P/E: —1d ago
Molecure S.A., a biotechnology company, engages in discovering, developing, and commercializing therapeutics for neoplastic and inflammatory diseases in Poland. The company is involved in the development of OATD-01, a ch…
Industry Peers
BiotechnologyKey Statistics
Company
Market Cap38.51M $
Enterprise Value27.92M $
Revenue (TTM)1.65M $
Gross Profit-863.37K $
Net Income (TTM)-7.92M $
Revenue/Share0.0800 USD
Last Price6.180 PLN
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees—
CountryPL
SectorHealthcare
IndustryBiotechnology
ISINPLONCTH00011
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-7.05
EV/Revenue16.91
P/S23.44
P/B1.42
EPS (TTM)-0.99
EPS (Forward)—
52W Range
4.98029% of range9.060
52W High9.060 PLN
52W Low4.980 PLN
Profitability
Gross Margin-253.98%
Oper. Margin-61.33%
EBITDA Margin-239.77%
Profit Margin-240.64%
ROE-30.26%
ROA-27.51%
Growth
Revenue Growth29.00%
Earnings Growth—
Cash Flow & Leverage
Operating CF-14.43M $
CapEx (TTM)6.02M $
FCF Margin—
FCF Yield—
Net Debt-4.27M $
Net Debt/EBITDA1.08
Balance Sheet
Debt/Equity0.07
Current Ratio—
Quick Ratio—
Book Value/Sh4.340 PLN
Cash/Share1.090 PLN
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 PLN
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating1.0 (Strong Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)12.45 PLN
Upside (mean)+101.5%
Target Range9.900 PLN – 15.00 PLN
PLN9.900+101.5% to meanPLN15.00
# Analysts2
Ownership
Shares Out.24.72M
Float16.30M
Insiders29.29%
Institutions9.31%
Technical
SMA 505.848 (+5.7%)
SMA 2006.292 (-1.8%)
Beta1.00
S&P 52W Chg19.97%
Avg Vol (30d)38.62K
Avg Vol (10d)33.26K
Technical Indicators
RSI (14)62.9
MACD0.0975
MACD Signal0.0443
MACD Hist.+0.0533
BB Upper6.185 PLN
BB Middle5.737 PLN
BB Lower5.288 PLN
BB Width15.62%
ATR (14)0.2994 PLN
Vol Ratio (20d)1.11x